← Leaderboards
Angela Meier
University Of California, San Diego
$1,009,165
Attributed
$3,027,494
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$3,027,494 · 1
By mechanism
R01$3,027,494 · 1
Top collaborators
- Victor Nizet3 shared
- Liangfang Zhang3 shared
Most similar at University Of California, San Diego
Same institution · by research overlap
- Victor Nizet$31,303,620
- Michael J Sailor$3,905,383
- Robert Alan Shalwitz$1,309,009
- Nathan Claude Gianneschi$7,501,389
- Jason X.-J. Yuan$26,627,598
Others in their field
Other Rising Stars on “3-Dimensional”
- Daofeng Li · Salk Institute For Biological Studies$9,887,266
- Ons M'saad · Panluminate Inc.$4,058,447
- Rebecca Bradford · American Type Culture Collection$3,862,721
- Pei-Hsun Wu · Johns Hopkins University$3,570,953
- Fang Liu · Massachusetts General Hospital$3,379,144
- Ruben Dries · Boston Medical Center$3,371,645
Research focus
3-DimensionalAcinetobacter BaumanniiAcinetobacter Baumannii PneumoniaAcute Respiratory Distress SyndromeAlveolar MacrophagesAnti-Bacterial AgentsAntibioticsAntimicrobial ResistanceApoptosisBacterial PneumoniaBacterial ToxinsBindingBiodegradable PolymerBiomaterial CompatibilityBiomimeticsBlood DonorBrain InjuriesCarbapenemsCaringCell InjuryCell MembraneCessation Of LifeClinical Development2019-Ncov
Grant awards (3)
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia$991,226
R01 · FY2025 · AI
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia$1,009,268
R01 · FY2024 · AI
Biomimetic Macrophage Membrane-Coated Nanosponges: A Novel Therapeutic for Multidrug-Resistant Pseudomonas aeruginosa and Acinetobacter baumannii Hospital-Associated Pneumonia$1,027,000
R01 · FY2023 · AI